Innate Pharma (IPHA) Asset Utilization Ratio (2022 - 2024)
Historic Asset Utilization Ratio for Innate Pharma (IPHA) over the last 6 years, with Q2 2025 value amounting to 0.12.
- Innate Pharma's Asset Utilization Ratio fell 3469.71% to 0.12 in Q2 2025 from the same period last year, while for Jun 2025 it was 0.12, marking a year-over-year decrease of 3469.71%. This contributed to the annual value of 0.14 for FY2024, which is 5765.08% down from last year.
- As of Q2 2025, Innate Pharma's Asset Utilization Ratio stood at 0.12, which was down 3469.71% from 0.16 recorded in Q4 2024.
- Innate Pharma's 5-year Asset Utilization Ratio high stood at 0.19 for Q2 2024, and its period low was 0.0 during Q4 2021.
- In the last 5 years, Innate Pharma's Asset Utilization Ratio had a median value of 0.11 in 2023 and averaged 0.09.
- Per our database at Business Quant, Innate Pharma's Asset Utilization Ratio crashed by 4356.96% in 2021 and then soared by 2814478.75% in 2022.
- Quarter analysis of 5 years shows Innate Pharma's Asset Utilization Ratio stood at 0.0 in 2021, then surged by 28144.79% to 0.07 in 2022, then soared by 150.19% to 0.17 in 2023, then dropped by 3.9% to 0.16 in 2024, then dropped by 23.98% to 0.12 in 2025.
- Its Asset Utilization Ratio was 0.12 in Q2 2025, compared to 0.16 in Q4 2024 and 0.19 in Q2 2024.